These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study. Burkhalter F; Oettl T; Descoeudres B; Bachmann A; Guerke L; Mihatsch MJ; Dickenmann M; Steiger J Transplant Proc; 2012 Dec; 44(10):2961-5. PubMed ID: 23195006 [TBL] [Abstract][Full Text] [Related]
4. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients. Oh CK; Huh KH; Ha J; Kim YH; Kim YL; Kim YS Transplantation; 2015 Jan; 99(1):180-6. PubMed ID: 24983307 [TBL] [Abstract][Full Text] [Related]
6. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy. Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189 [TBL] [Abstract][Full Text] [Related]
7. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598 [TBL] [Abstract][Full Text] [Related]
8. Can we eliminate both calcineurin inhibitors and steroids? Lebranchu Y Transplant Proc; 2010 Nov; 42(9 Suppl):S25-8. PubMed ID: 21095446 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation. Cibrik D; Silva HT; Vathsala A; Lackova E; Cornu-Artis C; Walker RG; Wang Z; Zibari GB; Shihab F; Kim YS Transplantation; 2013 Apr; 95(7):933-42. PubMed ID: 23422495 [TBL] [Abstract][Full Text] [Related]
10. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis. Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy. Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD Transplant Proc; 2005 Oct; 37(8):3538-41. PubMed ID: 16298653 [TBL] [Abstract][Full Text] [Related]
14. Good outcomes with cyclosporine very low exposure with everolimus high exposure in renal transplant patients. Bertoni E; Larti A; Rosso G; Zanazzi M; Di Maria L; Salvadori M J Nephrol; 2011; 24(5):613-8. PubMed ID: 21240873 [TBL] [Abstract][Full Text] [Related]
15. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation. Roodnat JI; Hilbrands LB; Hené RJ; de Sévaux RG; Smak Gregoor PJ; Kal-van Gestel JA; Konijn C; van Zuilen A; van Gelder T; Hoitsma AJ; Weimar W Transplantation; 2014 Jul; 98(1):47-53. PubMed ID: 24521775 [TBL] [Abstract][Full Text] [Related]
16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
17. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience. Santos SM; Carlos CM; Cabanayan-Casasola CB; Danguilan RA Transplant Proc; 2012 Jan; 44(1):154-60. PubMed ID: 22310603 [TBL] [Abstract][Full Text] [Related]
18. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Tönshoff B; Höcker B Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497 [TBL] [Abstract][Full Text] [Related]
19. Reduced-dose cyclosporine with mycophenolate mofetil and prednisone significantly improves the long-term glomerular filtration rate and graft survival. Wang R; Xu Y; Wu J; Wang Y; He Q; Chen J Intern Med; 2013; 52(9):947-53. PubMed ID: 23648712 [TBL] [Abstract][Full Text] [Related]
20. Conversion from cyclosporine to sirolimus in chronic renal allograft dysfunction: a 4-year prospective study. Han F; Wu J; Huang H; Zhang X; He Q; Wang Y; Wang S; Wang H; Chen J Exp Clin Transplant; 2011 Feb; 9(1):42-9. PubMed ID: 21605022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]